Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: endocrine: on day of life 133, , a random blood sugar obtained with routine laboratory studies was found to be 50. this prompted regular blood sugar monitoring, and infant was found to have recurrent hypoglycemia. most sugars were within normal limits, but infant was noted to have periodic sugars under 50 and even under 40. occurrences of hypoglycemia appeared to be unrelated to volume or frequency of enteral intake. she was evaluated by the endocrine service, and extensive endocrine and metabolic testing was performed. electrolytes, ph, lactate, pyruvate, growth hormone levels, cortisol levels, serum amino acids, urine organic acids, serum acylcarnitine panel, and repeat newborn screen were all within normal limits. multiple insulin levels were checked while infant was hypoglycemic; several levels were thought to be inappropriately high, between 3 and 5 uiu/ml. with a presumed diagnosis of hyperinsulinism, thought secondary to prematurity and degree of illness, she was started on diazoxide 15 mg/kg/day on . occasional sugars under 50 were still seen over the next several days, but glycemic control gradually improved. between and , blood sugars were all above 70, except for one sugar of 51 associated with lower enteral intake than usual. with good stability of sugars seen, plans were made to discharge infant to home, with continued monitoring of blood sugars by family and close follow-up with endocrinology service. gastrointestinal: was treated with phototherapy for physiologic hyperbilirubinemia from day of life 1 to day of life 25. her peak bilirubin on day of life 20 was total of 5.1, direct of 0.1. she also developed direct hyperbilirubinemia due to prolonged pn administration, with a peak direct bilirubin on of 5.0 with total bilirubin of 6.5. she also had mildly elevated transaminase levels at that time, as well as elevated coagulation studies with pt of 14 to 15 and ptt of approximately 60. an abdominal ultrasound on was completely within normal limits. consultation with the gastroenterology service from was obtained, and she was treated with ursodiol and weekly vitamin k injections for several. laboratory studies gradually improved, and medications were eventually discontinued. her labs on , day of life 154, were alt 35, ast 32, alkaline phosphatase of 638, bilirubin total 0.9 and direct 0.5. all labs were improved except alkaline phosphatase which was stable. pt and ptt on were stable with pt 14.2 and ptt 61. she is also being treated with prilosec for gastroesophageal reflux since day of life 108 and that continues at the time of discharge. hematology: she has blood type o positive, dat negative. her last hematocrit on was 29.8 with a reticulocyte count of 2.3%. she had 10 transfusions of packed red blood cells during her nicu stay, the last one on , and she was maintained on iron supplementation. infectious disease: was started on ampicillin and gentamycin at the time of admission for sepsis risk factors. she completed 7 days of antibiotics therapy for presumed sepsis. her blood and cerebrospinal fluid culture remained negative from that time. she was started on vancomycin and gentamycin on day of life 10 for clinical presentation of sepsis. the antibiotics were discontinued after 48 hours and the blood culture was negative and she was clinically well. on day of life 56, she completed a 14 day course of gentamycin and ceftazidime for proteus pneumonia. a follow-up tracheal aspirate showed normal flora. on day of life 57, she presented with bilious vomiting and was started on zosyn and completed 10 days for concerns of nec while underlying a gastrointestinal evaluation. on day of life 96, she was started on vancomycin and zosyn when she presented with blood in her stool. the antibiotics were discontinued when the blood was felt to be consistent with formula intolerance. she has remained off antibiotics since that time. neurology: her first head ultrasound on showed bilateral intraventricular hemorrhage, grade ii. serial ultrasounds revealed evolving intraventricular hemorrhage and some increasing ventriculomegaly that then subsequently resolved by . her last head ultrasound on showed no ventricular dilatation and no evidence of intraventricular hemorrhage. exam has been largely normal with mildly increased tone throughout. ophthalmology: cydnei was noted to develop retinopathy of prematurity, to stage ii in zone ii bilaterally. this subsequently regessed, and her eyes were examined most recently on revealing mature retinal vessels. a follow-up examination is recommended in 9 months. psychosocial: the parents have been very involved during nicu stay. her parents were married during this stay. her dad is and mom is . their last name is and that will be last name after discharge. the infant is discharged in good condition. she is discharged home with her parents. discharge physical exam: at the time of discharge, the infant's weight is 3815 grams, the length is 48.5 cm and the head circumference is 35 cm. exam reveals a vigorous, nondysmorphic, term-appearing female. anterior fontanel soft and flat. mild dolicocephaly. positive bilateral red reflex. eyes without drainage. oral mucosa without lesions. neck supple and without masses. clavicles intact. comfortable respirations. lung sounds clear and equal. grade 1/6 systolic ejection murmur at the left sternal border, pink and well perfused. femoral pulses present. abdomen soft, nontender, nondistended and with active bowel sounds and a very small umbilical hernia. no hepatosplenomegaly. some mild nasal stuffiness and an occasional soft cough. no sacral anomalies. very mild inguinal edema and normal digits and creases. stable hip examination but overall, mildly increased tone. primary pediatric care provider: , md, pediatric associates of greater , ., , , telephone number . recommendations after discharge: feedings: neocate 26 calories per ounce with 4 calories by concentration and 2 calories by corn oil. we recommend that she remain on the neocate formula until she is one year of age, although caloric density may be able to be decreased in the near future. medications: 1. ferrous sulfate (25 mg/ml) 0.3 ml p.o. daily. 2. multi-vitamins one ml p.o. daily. 3. prilosec (omeprazole) 3 mg po daily (equivalent to 1 mg/kg/day). 4. diazoxide 18 mg p.o. every 8 hours (15 mg/kg per day divided in 3 doses), equal to 0.4 ml po 3x/day. the parents will continue to check her glucometer and glucose readings 2 to 3 times a day before her feedings. they have been instructed to contact their physician or their endocrinologist for a glucose level less than 60 or greater than 150. the parents have also been given an emergency glucagon kit, to be used only in a situation where infant is non-responsive and hypoglycemic. they have been instructed to give of the full dose of the glucagon kit ( ml) if necessary. iron supplementation is recommended for preterm and low birth weight infants until 12 months corrected age. the infant did not pass her car seat position screening test and will be discharged home in a car bed. her last routine newborn screen was sent on and was within normal limits. a repeat newborn screen was sent on during the evaluation of hypoglycemia, and this was also normal. she has received the following immunizations: hepatitis b #1 on . pediarix on . hib on . pneumococcal 7-falent conjugate . synagis on (due to exposure within the unit). recommended immunizations: synagis rsv prophylaxis should be considered from through for infants who meet any of the following four criteria: (1) born at less than 32 weeks; (2) born between 32 weeks and 35 weeks with two of the following: day care during rsv season, a smoker in the household, neuromuscular disease, airway abnormalities or school age siblings; (3) chronic lung disease or (4) hemodynamically significant congenital heart disease. influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age. before this age, and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out-of-home caregivers. this infant has not received rota virus vaccine. the american academy of pediatrics recommends initial vaccination of preterm infants at or following discharge from the hospital if they are clinically stable or at least 6 weeks but fewer than 12 weeks of age. followup: 1. early intervention up at infant/toddler development program at in , . telephone number . 2. health , telephone number . 3. infant follow-up program. telephone number . they will contact the family for an appointment. 4. ophthalmology: dr. , telephone number , recommended in 9 months. 5. the liver clinic at , appointment for at 8:30 a.m. with dr. , telephone number . 6. orl, dr. , telephone number . to be seen 2 weeks after discharge. clinic will contact family. 7. endocrine service, dr. , beeper #. he will contact the family for an appointment. discharge diagnoses: 1. status post prematurity at 24 weeks gestation. 2. status post respiratory distress syndrome. 3. status post apnea of prematurity. 4. status post physiologic hyperbilirubinemia. 5. status post direct hyperbilirubinemia due to pn cholestasis. 6. status post anemia of prematurity. 7. status post retinopathy of prematurity. 8. chronic lung disease. 9. status post patent ductus arteriosus. 10. status post patent ductus ligation. 11. status post proteus pneumonia. 12. status post bilateral intraventricular hemorrhage. 13. status post ventriculomegaly. 14. gastroesophageal reflux. 15. status post cow's milk protein intolerance. 16. status post presumed sepsis. 17. vocal cord granuloma. , md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours parenteral infusion of concentrated nutritional substances enteral infusion of concentrated nutritional substances transfusion of packed cells diagnoses: abnormal coagulation profile esophageal reflux chronic respiratory disease arising in the perinatal period anemia of prematurity other specified conditions originating in the perinatal period retrolental fibroplasia septicemia [sepsis] of newborn ostium secundum type atrial septal defect other specified disorders of biliary tract other specified hypoglycemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] allergic gastroenteritis and colitis other diseases of larynx, not elsewhere classified other disease of nasal cavity and sinuses 

Answer: The patient is high likely exposed to